OrgUnit's Researchers
(Persons)

Results 1-5 of 20 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Baker, AmyAmy.BAKER@austin.org.au
Balasubramanian, Adithyaadithya.balasubramanian@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au
Cher, Lawrence MLawrence.CHER@austin.org.au
Fancourt, TinekeTineke.FANCOURT@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 401-420 of 548 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
40130-Apr-2014Prostate Cancer - Double vision but solitary lesionLim, Hui Yin; Perchyonok, Yuliya ; Fitt, Gregory J ; Lokan, Julie ; Wada, Morikatsu ; Fabinyi, Gavin C ; Azad, A; Cher, Lawrence M ; Gan, Hui K 
402Feb-2023A protocol for a prospective, multicentre observational study to determine if nonanaemic iron deficiency worsens postoperative outcome in patients undergoing elective surgery for resection of colorectal cancer: The NATO study.Miles, Lachlan F ; Pac Soo, Vanessa; Braat, Sabine; Burgess, Adele N ; Heritier, Stephane; Smart, Philip J ; Tan, Nicole; Parker, Anna; Burbury, Kate L; Story, David A 
4036-Jun-2012Pulmonary metastases: a rare manifestation of the most common cancer.Arulananda, Surein; Liew, Mun Sem; Battye, Shane; McDonald, Christine F ; Mitchell, Paul L R 
40421-Feb-2020Quality indicators in colonoscopy: an evolving paradigm.Shine, Rebecca; Bui, Andrew ; Burgess, Adele N 
40530-May-2014Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma.Ciprotti, Marika; Chong, Geoffrey ; Gan, Hui K ; Chan, Anthony; Murone, Carmel ; MacGregor, Duncan; Lee, Fook-Thean; Johns, Terrance G; Heath, Joan K; Ernst, Matthias ; Burgess, Antony W; Scott, Andrew M 
40611-Mar-2022Radiolabeled Antibodies for Cancer Imaging and Therapy.Parakh, Sagun ; Lee, Sze Ting ; Gan, Hui K ; Scott, Andrew M 
407Sep-2021Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa.Burvenich, Ingrid J G; Goh, Yit Wooi; Guo, Nancy; Gan, Hui K ; Rigopoulos, Angela; Cao, Diana; Liu, Zhanqi; Ackermann, Uwe ; Wichmann, Christian Werner; McDonald, Alexander Franklin; Huynh, Nhi; O'Keefe, Graeme Joseph; Gong, Sylvia Jie; Scott, Fiona Elizabeth; Li, Linghui; Geng, Wanping; Zutshi, Anup; Lan, Yan; Scott, Andrew M 
40812-Jan-2010Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.Tebbutt, Niall C ; Cummins, M M; Sourjina, T; Strickland, A; Van Hazel, G; Ganju, V; Gibbs, D; Stockler, M; Gebski, V; Zalcberg, John R
4097-Nov-2022Randomized Controlled Trial of a Smartphone Based Intervention to Enhance Six Minute Walk Distance During Breast Cancer Treatment: the SMART-BREAST Trial.Murphy, Alexandra C ; Farouque, Omar ; Koshy, Anoop N ; Yeo, Belinda ; Dick, Ron; Nadurata, Voltaire; Roccisano, Laura; Reid, Christopher; Yudi, Matias B 
41023-May-2011Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer.Mitchell, Paul L R ; Broad, Adam; Rosenthal, Mark A; Galettis, Peter; Abraham, Rick; Burns, Ivon; Clarke, Stephen; Milner, Alvin; Diiulio, Juliana; Links, Matthew
4111-Nov-2021A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD).Mitchell, Paul L R ; O'Byrne, K J; Brown, C; Jurkovic, H; Karapetis, C S; Kok, P S; Lao, L; Le, H V; Pavlakis, N; Ab Rahman, A S; Subramaniam, S; Walker, M; Yip, S; Stockler, M R; Siva, S
41211-Jun-2014Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.Van Cutsem, Eric; Eng, Cathy; Nowara, Elzbieta; Swieboda-Sadlej, Anna; Tebbutt, Niall C ; Mitchell, Edith; Davidenko, Irina; Stephenson, Joe; Elez, Elena; Prenen, Hans; Deng, Hongjie; Tang, Rui; McCaffery, Ian; Oliner, Kelly S; Chen, Lisa; Gansert, Jennifer; Loh, Elwyn; Smethurst, Dominic; Tabernero, Josep
413Sep-2016A randomized phase II study of FOLFOX with or without the MET inhibitor onartuzumab in advanced adenocarcinoma of the stomach and gastroesophageal junctionShah, Manish A; Cho, Jae-Yong; Tan, Iain B; Tebbutt, Niall C ; Yen, Chia-Jui; Kang, Alice; Shames, David S; Bu, Lilian; Kang, Yoon-Koo
414Apr-2017Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.García-Carbonero, Rocío; van Cutsem, Eric; Rivera, Fernando; Jassem, Jacek; Gore, Ira; Tebbutt, Niall C ; Braiteh, Fadi; Argiles, Guillem; Wainberg, Zev A; Funke, Roel; Anderson, Maria; McCall, Bruce; Stroh, Mark; Wakshull, Eric; Hegde, Priti; Ye, Weilan; Chen, Daniel; Chang, Ilsung; Rhee, Ina; Hurwitz, Herbert
415May-2022A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer.Capdevila, Jaume; Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Hughes, Brett G M; Keam, Bhumsuk; Parnis, Francis; Elisei, Rossella; Gajate, Pablo; Gan, Hui K ; Kapiteijn, Ellen; Locati, Laura; Mangeshkar, Milan; Faoro, Leonardo; Krajewska, Jolanta; Jarzab, Barbara
41626-May-2022Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarcinoma.Shah, Manish A; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C ; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily; Xu, Bo; Li, Wei; Li, Chiang J; Borodyansky, Laura; Van Cutsem, Eric
41714-Jul-2022Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Shah, Manish A; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C ; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M; Xu, Bo; Li, Wei; Li, Chiang J; Borodyansky, Laura; Van Cutsem, Eric
41822-Feb-2021Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK.Lau, David K ; Luk, Ian Y; Jenkins, Laura J; Martin, Andrew; Williams, David S ; Schoffer, Kael L; Chionh, Fiona; Buchert, Michael; Sjoquist, Katrin; Boussioutas, Alex; Hayes, Sarah A; Ernst, Matthias ; Weickhardt, Andrew J ; Pavlakis, Nick; Tebbutt, Niall C ; Mariadason, John M 
419Oct-2021A rare case of solitary gallbladder metastasis from an early cutaneous melanoma.Doole, Emily Louise; Gan, Philip; Klein, Oliver 
42028-Jun-2021Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapy.Hepner, Adriana; Atkinson, Victoria G; Larkin, James; Burrell, Rebecca A; Carlino, Matteo S; Johnson, Douglas B; Zimmer, Lisa; Tsai, Katy K; Klein, Oliver ; Lo, Serigne N; Haydon, Andrew; Bhave, Prachi; Lyle, Megan; Pallan, Lalit; Pires da Silva, Ines; Gerard, Camille; Michielin, Olivier; Long, Georgina V; Menzies, Alexander M